{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3e37e103-a72b-4bcf-a772-30b6cfbb8f53",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "8b93bb10-4c9e-4d8b-b6eb-f3e2d8f66b45",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "#%%writefile shakti3_index.py\n",
    "# NOTE: This is ONLY necessary in jupyter notebook.\n",
    "# Details: Jupyter runs an event-loop behind the scenes. \n",
    "#          This results in nested event-loops when we start an event-loop to make async queries.\n",
    "#          This is normally not allowed, we use nest_asyncio to allow it for convenience.  \n",
    "# import nest_asyncio\n",
    "# nest_asyncio.apply()\n",
    "\n",
    "# PydanticMultipleSelector\n",
    "# Use the OpenAI Function API to generate/parse pydantic objects under the hood for the router selector.\n",
    "from llama_index.query_engine.router_query_engine import RouterQueryEngine\n",
    "from llama_index.selectors.llm_selectors import LLMSingleSelector, LLMMultiSelector\n",
    "from llama_index.selectors.pydantic_selectors import PydanticMultiSelector, PydanticSingleSelector\n",
    "from llama_index.tools.query_engine import QueryEngineTool\n",
    "from llama_index.objects import ObjectIndex, SimpleToolNodeMapping\n",
    "from llama_index.query_engine import ToolRetrieverRouterQueryEngine\n",
    "from langchain.chat_models import ChatOpenAI\n",
    "\n",
    "import openai\n",
    "import os\n",
    "import json\n",
    "os.environ[\"OPENAI_API_KEY\"] = \"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\"\n",
    "openai.api_key = \"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\"\n",
    "\n",
    "import logging\n",
    "import sys\n",
    "\n",
    "logging.basicConfig(stream=sys.stdout, level=logging.INFO)\n",
    "logging.getLogger().handlers = []\n",
    "logging.getLogger().addHandler(logging.StreamHandler(stream=sys.stdout))\n",
    "\n",
    "from llama_index import (\n",
    "    VectorStoreIndex,\n",
    "    ListIndex,\n",
    "    SimpleDirectoryReader,\n",
    "    ServiceContext,\n",
    "    StorageContext,\n",
    "    SimpleKeywordTableIndex,\n",
    "    LLMPredictor,\n",
    ")\n",
    "\n",
    "def llama_listvectorkeyword_index(uploaded_file, query):\n",
    "    # load documents\n",
    "    documents = SimpleDirectoryReader(input_files = [uploaded_file]).load_data()\n",
    "    \n",
    "    # initialize service context (set chunk size)\n",
    "    #service_context = ServiceContext.from_defaults(chunk_size=1024)\n",
    "    llm_predictor_gpt4 = LLMPredictor(llm=ChatOpenAI(temperature=0, model_name=\"gpt-4-32k\"))\n",
    "    service_context = ServiceContext.from_defaults(llm_predictor=llm_predictor_gpt4, chunk_size=1024, chunk_overlap=100)\n",
    "    nodes = service_context.node_parser.get_nodes_from_documents(documents)\n",
    "\n",
    "    # initialize storage context (by default it's in-memory)\n",
    "    storage_context = StorageContext.from_defaults()\n",
    "    storage_context.docstore.add_documents(nodes)\n",
    "\n",
    "    #Define List Index and Vector Index over Same Data\n",
    "    list_index = ListIndex(nodes, storage_context=storage_context)\n",
    "    vector_index = VectorStoreIndex(nodes, storage_context=storage_context)\n",
    "\n",
    "    #Define Query Engines and Set Metadata\n",
    "    list_query_engine = list_index.as_query_engine(\n",
    "        response_mode='tree_summarize',\n",
    "        use_async=True,\n",
    "    )\n",
    "    vector_query_engine = vector_index.as_query_engine()\n",
    "\n",
    "    list_tool = QueryEngineTool.from_defaults(\n",
    "        query_engine=list_query_engine,\n",
    "        description='Useful for summarization questions',\n",
    "    )\n",
    "\n",
    "    vector_tool = QueryEngineTool.from_defaults(\n",
    "        query_engine=vector_query_engine,\n",
    "        description='Useful for retrieving specific context from a particular section or paragraph.',\n",
    "\n",
    "    )\n",
    "\n",
    "    #Define Keyword Query Engine\n",
    "    keyword_index = SimpleKeywordTableIndex(nodes, storage_context=storage_context)\n",
    "    keyword_query_engine = keyword_index.as_query_engine()\n",
    "    keyword_tool = QueryEngineTool.from_defaults(\n",
    "        query_engine=vector_query_engine,\n",
    "        description='Useful for retrieving specific context using keywords',\n",
    "    )\n",
    "\n",
    "    query_engine = RouterQueryEngine(\n",
    "        selector=PydanticMultiSelector.from_defaults(),\n",
    "        query_engine_tools=[\n",
    "            list_tool,\n",
    "            vector_tool,\n",
    "            keyword_tool,\n",
    "        ]\n",
    "    )\n",
    "\n",
    "    #Define Retrieval-Augmented Router Query Engine\n",
    "    tool_mapping = SimpleToolNodeMapping.from_objects([list_tool, vector_tool, keyword_tool])\n",
    "    obj_index = ObjectIndex.from_objects(\n",
    "        [list_tool, vector_tool, keyword_tool], \n",
    "        tool_mapping,\n",
    "        VectorStoreIndex,\n",
    "    )\n",
    "\n",
    "    query_engine = ToolRetrieverRouterQueryEngine(obj_index.as_retriever())\n",
    "\n",
    "    return query_engine.query(query)\n",
    "\n",
    "def prompt(file):\n",
    "    with open(file, encoding=\"utf8\") as f:\n",
    "        return f.read()\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "9f9c0b12-5d7b-401d-aa28-48aa9b9617f1",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Combining responses from multiple query engines.\n"
     ]
    }
   ],
   "source": [
    "intro_query = \"Strictly following the above instructions and the clinical trial document provided, write the content of 'Introduction' \\\n",
    "section of the APLS in past tense, comprehendable by a scientific researcher. Do not violate the section-wise instructions provided \\\n",
    "in any case. The content should be strictly inferred from the clinical trial document provided only and not any other sources.\\n\"\n",
    "\n",
    "\n",
    "intro_response = llama_listvectorkeyword_index('RCT.pdf', (prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + intro_query))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "f38f75e2-6f5e-43e0-a19a-28fce69b5ce9",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Combining responses from multiple query engines.\n",
      "\n",
      "This study investigated the efficacy of pembrolizumab and encorafenib plus cetuximab compared with pembrolizumab alone as a first-line treatment for BRAF V600E-mutant microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (CRC). The SEAMARK study was a randomized phase 2 clinical trial sponsored by Novartis Pharmaceuticals Corporation and conducted at multiple sites in the United States, Canada, and Europe. A total of 120 participants with BRAF V600E-mutant MSI-H/dMMR metastatic CRC were randomized in a 1:1 ratio to receive either pembrolizumab alone or pembrolizumab plus encorafenib plus cetuximab. The primary endpoint was progression-free survival (PFS) and the secondary endpoints were overall survival (OS), objective response rate (ORR), and safety.\n"
     ]
    }
   ],
   "source": [
    "intro_summary_query = \"Strictly following the above instructions and the clinical trial document provided, write the content of 'Intro Summary' \\\n",
    "section of the APLS in past tense, comprehendable by a scientific researcher. Do not violate the section-wise instructions provided \\\n",
    "in any case. The content should be strictly inferred from the clinical trial document provided only and not any other sources.\\n\"\n",
    "\n",
    "\n",
    "print(llama_listvectorkeyword_index('RCT.pdf', (prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + \"Here is the Introduction section generated: \"+ \n",
    "                                    str(intro_response) + intro_summary_query)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "a143a964-0059-4725-ac63-be7342ba930a",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Combining responses from multiple query engines.\n",
      "\n",
      "Inclusion criteria:\n",
      "- Participants were aged 18 years or older\n",
      "- Participants had histologically or cytologically confirmed metastatic colorectal cancer\n",
      "- Participants had BRAF V600E mutation\n",
      "- Participants had microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) tumors\n",
      "- Participants had an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1\n",
      "- Participants had adequate organ function\n"
     ]
    }
   ],
   "source": [
    "inclusion_criteria_query = \"Strictly following the above instructions and the clinical trial document provided, write the content of \\\n",
    "'Inclusion criteria' section of the APLS in past tense, comprehendable by a scientific researcher. Do not violate the section-wise instructions provided \\\n",
    "in any case. The content should be strictly inferred from the clinical trial document provided only and not any other sources.\\n\"\n",
    "\n",
    "\n",
    "print(llama_listvectorkeyword_index('RCT.pdf', (prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + inclusion_criteria_query)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "ee4536f9-fea7-4bb3-be43-ff6b7fa0b33e",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Combining responses from multiple query engines.\n",
      "\n",
      "The Exclusion criteria for this study were:\n",
      "- Participants with a history of any other malignancy within the past 5 years, except for adequately treated non-melanoma skin cancer or carcinoma in situ of the cervix.\n",
      "- Participants with known brain metastases or leptomeningeal disease.\n",
      "- Participants with known active hepatitis B or C virus infection.\n",
      "- Participants with known human immunodeficiency virus (HIV) infection.\n",
      "- Participants with known active tuberculosis.\n",
      "- Participants with known hypersensitivity to any of the study drugs or their excipients.\n"
     ]
    }
   ],
   "source": [
    "exclusion_criteria_query = \"Strictly following the above instructions and the clinical trial document provided, write the content of \\\n",
    "'Exclusion criteria' section of the APLS in past tense, comprehendable by a scientific researcher. Do not violate the section-wise instructions provided \\\n",
    "in any case. The content should be strictly inferred from the clinical trial document provided only and not any other sources.\\n\"\n",
    "\n",
    "\n",
    "print(llama_listvectorkeyword_index('RCT.pdf', (prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + exclusion_criteria_query)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "f085a111-63c0-4aaa-9a78-388374440a89",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Combining responses from multiple query engines.\n",
      "\n",
      "545\n"
     ]
    }
   ],
   "source": [
    "participants_query = \"Strictly following the above instructions and the clinical trial document provided, generate in one word the \\\n",
    "'Participants' section of the APLS in past tense, comprehendable by a scientific researcher. Do not violate the section-wise instructions provided \\\n",
    "in any case. The content should be strictly inferred from the clinical trial document provided only and not any other sources.\\n\"\n",
    "\n",
    "\n",
    "print(llama_listvectorkeyword_index('RCT.pdf', (prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + participants_query)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "449f457c-9b67-496d-986d-b6c830602b6a",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Combining responses from multiple query engines.\n",
      "Colorectal cancer\n"
     ]
    }
   ],
   "source": [
    "disease_condition_query = \"Strictly following the above instructions and the clinical trial document provided, generate in 2-3 words the specific \\\n",
    "'Disease condition' mentioned in the APLS in past tense, comprehendable by a scientific researcher. Do not violate the section-wise instructions provided \\\n",
    "in any case. The content should be strictly inferred from the clinical trial document provided only and not any other sources.\\n\"\n",
    "\n",
    "\n",
    "print(llama_listvectorkeyword_index('RCT.pdf', (prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + disease_condition_query)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "71676766-3f4e-4bbe-8226-e8e6ad9ff58d",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Combining responses from multiple query engines.\n",
      "\n",
      "The study included 441 participants aged 18 to 75 years, with a median age of 57 years. The majority of the participants were male (68.2%) and white (83.2%). The participants were from the United States (68.2%), Europe (25.2%), and other countries (6.6%).\n"
     ]
    }
   ],
   "source": [
    "demographics_query = \"Strictly following the above instructions and the clinical trial document provided, write the content of \\\n",
    "'Demographics' section of the APLS in past tense, comprehendable by a scientific researcher. Do not violate the section-wise instructions provided \\\n",
    "in any case. The content should be strictly inferred from the clinical trial document provided only and not any other sources.\\n\"\n",
    "\n",
    "\n",
    "print(llama_listvectorkeyword_index('RCT.pdf', (prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + demographics_query)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "407c5db2-f2f0-4f83-8f95-b694be87f98d",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Combining responses from multiple query engines.\n",
      "\n",
      "39 participants\n"
     ]
    }
   ],
   "source": [
    "treatment_arm_query = \"Write in one number the count of participants only in the treatment arm\\n\"\n",
    "\n",
    "\n",
    "print(llama_listvectorkeyword_index('RCT.pdf', (prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + treatment_arm_query)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "6229a647-2f77-4625-a761-e581420461f9",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Combining responses from multiple query engines.\n",
      "\n",
      "50\n"
     ]
    }
   ],
   "source": [
    "control_arm_query = \"Write in one number the count of participnats in the control arm\"\n",
    "\n",
    "\n",
    "print(llama_listvectorkeyword_index('RCT.pdf', (prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + control_arm_query)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "dccd34de-4931-4839-9f7b-124eaae5671d",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b8bbc6ca-1b45-4cb7-8ac5-8870d2169575",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "90c7fb94-8d86-4c40-ab29-9610b48abc70",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Combining responses from multiple query engines.\n"
     ]
    },
    {
     "ename": "TypeError",
     "evalue": "'Response' object is not iterable",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[2], line 3\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[38;5;66;03m#from shakti_stream_index import llama_listvectorkeyword_index, prompt\u001b[39;00m\n\u001b[1;32m      2\u001b[0m summary_query \u001b[38;5;241m=\u001b[39m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mWith the above instructions and the clinical trial document provided, write a detailed APLS with mentioned sections in past tense, comprehendable by a grade 1 student. Provide the response in JSON format with section names as keys. Enclose each key in JSON in angular brackets for example \u001b[39m\u001b[38;5;124m'\u001b[39m\u001b[38;5;124m<Title>\u001b[39m\u001b[38;5;124m'\u001b[39m\u001b[38;5;124m. Enclose each value in JSON in double quotes. Make sure to complete the JSON with opening and closing flower brackets.\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m----> 3\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m text \u001b[38;5;129;01min\u001b[39;00m llama_listvectorkeyword_index(\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mRCT.pdf\u001b[39m\u001b[38;5;124m'\u001b[39m,prompt(\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mapls_persona_2606.txt\u001b[39m\u001b[38;5;124m'\u001b[39m) \u001b[38;5;241m+\u001b[39m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m \u001b[38;5;241m+\u001b[39m summary_query):\n\u001b[1;32m      4\u001b[0m     \u001b[38;5;28mprint\u001b[39m(text)\n",
      "\u001b[0;31mTypeError\u001b[0m: 'Response' object is not iterable"
     ]
    }
   ],
   "source": [
    "#from shakti_stream_index import llama_listvectorkeyword_index, prompt\n",
    "summary_query = \"With the above instructions and the clinical trial document provided, write a detailed APLS with mentioned sections in past tense, comprehendable by a grade 1 student. Provide the response in JSON format with section names as keys. Enclose each key in JSON in angular brackets for example '<Title>'. Enclose each value in JSON in double quotes. Make sure to complete the JSON with opening and closing flower brackets.\\n\"\n",
    "for text in llama_listvectorkeyword_index('RCT.pdf',prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + summary_query):\n",
    "    print(text)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "ed26c9e3-9261-4d10-8af2-70ef8dc112c7",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The main thing the researchers looked at was the percentage of people who had a hemoglobin response. The results showed that the combination of pembrolizumab and encorafenib plus cetuximab was more effective than pembrolizumab alone. The researchers also looked at other things, like the absolute change in hemoglobin level, the relative change in indirect bilirubin level, the relative change in the percentage of reticulocytes, and the relative change in lactate dehydrogenase level. The results showed that the combination of pembrolizumab and encorafenib plus cetuximab was more effective than pembrolizumab alone for all of these things.\n"
     ]
    }
   ],
   "source": [
    "print(response['<Results>'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "54349ccc-c5a7-4d54-923d-f302f43ab081",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 13499 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 62 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 1118 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 0 tokens\n",
      "> [get_response] Total LLM token usage: 2451 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 0 tokens\n",
      "> [get_response] Total LLM token usage: 2451 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n",
      "Combining responses from multiple query engines.\n",
      "> [get_response] Total LLM token usage: 2115 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n",
      "\n",
      "The SEAMARK study found that the combination of pembrolizumab and encorafenib plus cetuximab was more effective than pembrolizumab alone in treating BRAF V600E–mutant microsatellite instability–high (MSI-H)/mismatch repair–deficient (dMMR) metastatic colorectal cancer (CRC). The combination therapy was found to significantly improve progression-free survival (PFS) compared to pembrolizumab alone. The study was conducted on 120 participants with BRAF V600E–mutant microsatellite instability–high (MSI-H)/mismatch repair–deficient (dMMR) metastatic colorectal cancer (CRC) and was divided into two arms, with 60 participants in each arm. The first arm received pembrolizumab and encorafenib plus cetuximab, while the second arm received pembrolizumab alone. The results of the study suggest that the combination therapy may be a more effective treatment option for patients with BRAF V600E–mutant microsatellite instability–high (MSI-H)/mismatch repair–deficient (dMMR) metastatic colorectal cancer (CRC).\n",
      "None\n"
     ]
    }
   ],
   "source": [
    "summary_query = \"Strictly following the above instructions and the clinical trial document provided, write the content of 'Key takeaway' section of the APLS in past tense, comprehendable by a scientific researcher. Do not violate the section-wise instructions provided in any case. The content should be strictly inferred from the clinical trial document provided only and not any other sources.\\n\"\n",
    "llama_listvectorkeyword_index(prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + summary_query)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "7a6a5d54-1c44-4942-a5aa-b7824f675c62",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 13499 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 62 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 1118 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 0 tokens\n",
      "> [get_response] Total LLM token usage: 2364 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 0 tokens\n",
      "> [get_response] Total LLM token usage: 2364 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n",
      "Combining responses from multiple query engines.\n",
      "> [get_response] Total LLM token usage: 1889 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n",
      "\n",
      "The SEAMARK study was a randomized phase 2 study that aimed to compare the efficacy of pembrolizumab and encorafenib plus cetuximab with pembrolizumab alone as a first-line treatment for BRAF V600E-mutant microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (CRC). The study was sponsored by Novartis Pharmaceuticals Corporation and included a total of 120 participants, with 60 participants in each arm. The study was conducted at multiple sites in the United States, Canada, and Europe. \n",
      "\n",
      "The inclusion criteria for the study were: age 18 years or older, histologically confirmed diagnosis of metastatic CRC, BRAF V600E mutation, MSI-H/dMMR status, and ECOG performance status of 0 or 1. The exclusion criteria for the study were: prior systemic therapy for metastatic CRC, prior treatment with a BRAF or MEK inhibitor, and active brain metastases.\n",
      "None\n"
     ]
    }
   ],
   "source": [
    "summary_query = \"Strictly following the above instructions and the clinical trial document provided, write the content of 'Study details' section of the APLS in past tense, comprehendable by a scientific researcher. Do not violate the section-wise instructions provided in any case. The content should be strictly inferred from the clinical trial document provided only and not any other sources.\\n\"\n",
    "llama_listvectorkeyword_index(prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + summary_query)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "2ce4ce55-c498-43d6-99bf-a9dc7d982cdd",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 13499 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 62 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 1118 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 0 tokens\n",
      "> [get_response] Total LLM token usage: 2196 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 0 tokens\n",
      "> [get_response] Total LLM token usage: 2196 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n",
      "Combining responses from multiple query engines.\n",
      "> [get_response] Total LLM token usage: 1423 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n",
      "\n",
      "The aim of the SEAMARK study was to compare the efficacy and safety of pembrolizumab and encorafenib plus cetuximab with pembrolizumab alone as a first-line treatment for BRAF V600E-mutant microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (CRC).\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 13499 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 62 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 1117 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 0 tokens\n",
      "> [get_response] Total LLM token usage: 2434 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 0 tokens\n",
      "> [get_response] Total LLM token usage: 2434 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n",
      "Combining responses from multiple query engines.\n",
      "> [get_response] Total LLM token usage: 2139 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n",
      "\n",
      "The Results section of the APLS summarises the findings from the study. The primary endpoint of the study was overall survival (OS). The results showed that the median OS was not reached in the pembrolizumab plus encorafenib and cetuximab arm, while the median OS in the pembrolizumab alone arm was 11.2 months. The hazard ratio for death in the pembrolizumab plus encorafenib and cetuximab arm compared with the pembrolizumab alone arm was 0.62 (95% confidence interval [CI], 0.37 to 1.04; P=0.07). The secondary endpoints of the study included progression-free survival (PFS) and objective response rate (ORR). The median PFS was 8.4 months in the pembrolizumab plus encorafenib and cetuximab arm and 5.4 months in the pembrolizumab alone arm (hazard ratio for progression or death, 0.51; 95% CI, 0.33 to 0.78; P=0.002). The ORR was 68.2% in the pembrolizumab plus encorafenib and cetuximab arm and 44.4% in the pembrolizumab alone arm (odds ratio, 2.45; 95% CI, 1.17 to 5.14; P=0.02). The safety profile of the combination therapy was consistent with the known safety profiles of the individual agents.\n"
     ]
    }
   ],
   "source": [
    "summary_query = \"Strictly following the above instructions and the clinical trial document provided, write the content of 'Aims' section of the APLS in past tense, comprehendable by a scientific researcher. Do not violate the section-wise instructions provided in any case. The content should be strictly inferred from the clinical trial document provided only and not any other sources.\\n\"\n",
    "aims = llama_listvectorkeyword_index(prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + summary_query)\n",
    "\n",
    "\n",
    "summary_query = \"Strictly following the above instructions and the clinical trial document provided, write the content of 'Results' section of the APLS in past tense, comprehendable by a scientific researcher. Do not violate the section-wise instructions provided in any case. The content should be strictly inferred from the clinical trial document provided only and not any other sources.\\n\"\n",
    "results = llama_listvectorkeyword_index(prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + summary_query)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "926af74c-f3cf-4174-9539-5beae04e81ab",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 13499 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total LLM token usage: 0 tokens\n",
      "> [build_index_from_nodes] Total embedding token usage: 54 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 1117 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 0 tokens\n",
      "> [get_response] Total LLM token usage: 2193 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n",
      "> [retrieve] Total LLM token usage: 0 tokens\n",
      "> [retrieve] Total embedding token usage: 0 tokens\n",
      "> [get_response] Total LLM token usage: 2193 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n",
      "Combining responses from multiple query engines.\n",
      "> [get_response] Total LLM token usage: 1412 tokens\n",
      "> [get_response] Total embedding token usage: 0 tokens\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'\\nTitle: Effect of Pembrolizumab and Encorafenib Plus Cetuximab Compared with Pembrolizumab Alone in People with BRAF V600E-Mutant Microsatellite Instability-High (MSI-H)/Mismatch Repair-Deficient (dMMR) Metastatic Colorectal Cancer (CRC): Results of the SEAMARK Study'"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from shakti3_index import llama_listvectorkeyword_index, prompt\n",
    "summary_query = \"Strictly following the above instructions and the clinical trial document provided, write the content of 'Title' section of the APLS in past tense, comprehendable by a scientific researcher. Do not violate the section-wise instructions provided in any case. The content should be strictly inferred from the clinical trial document provided only and not any other sources.\\n\"\n",
    "llama_listvectorkeyword_index(\"/home/cdsw/experimentation_project1/PLS_project/data/RCT.pdf\", prompt('apls_persona_2606.txt') + \"\\n\\n\\n\" + summary_query)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f678e947-7f60-439e-9107-d344a551efea",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "51d02b57-5bd6-4d20-9020-3211ba54c565",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c759f9f2-b063-44e5-9ece-adcfae334bd3",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ddece691-f142-4fe4-815c-835ff4c9b931",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "338d262f-8c72-4042-9285-286931eb63c0",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Overwriting shakti_stream_index.py\n"
     ]
    }
   ],
   "source": [
    "%%writefile shakti_stream_index.py\n",
    "#current working version for streaming\n",
    "# NOTE: This is ONLY necessary in jupyter notebook.\n",
    "# Details: Jupyter runs an event-loop behind the scenes. \n",
    "#          This results in nested event-loops when we start an event-loop to make async queries.\n",
    "#          This is normally not allowed, we use nest_asyncio to allow it for convenience.  \n",
    "# import nest_asyncio\n",
    "# nest_asyncio.apply()\n",
    "\n",
    "# PydanticMultipleSelector\n",
    "# Use the OpenAI Function API to generate/parse pydantic objects under the hood for the router selector.\n",
    "\n",
    "from langchain.chat_models import ChatOpenAI\n",
    "from llama_index.llms import OpenAI\n",
    "import streamlit as st\n",
    "import time\n",
    "import openai\n",
    "import os\n",
    "import json\n",
    "os.environ[\"OPENAI_API_KEY\"] = \"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\"\n",
    "openai.api_key = \"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\"\n",
    "\n",
    "import logging\n",
    "import sys\n",
    "\n",
    "logging.basicConfig(stream=sys.stdout, level=logging.INFO)\n",
    "logging.getLogger().handlers = []\n",
    "logging.getLogger().addHandler(logging.StreamHandler(stream=sys.stdout))\n",
    "\n",
    "from llama_index import (\n",
    "    VectorStoreIndex,\n",
    "    ListIndex,\n",
    "    SimpleDirectoryReader,\n",
    "    ServiceContext,\n",
    "    StorageContext,\n",
    "    SimpleKeywordTableIndex,\n",
    "    LLMPredictor,\n",
    ")\n",
    "\n",
    "def llama_vector_index(uploaded_file, query):\n",
    "    # load documents\n",
    "    documents = SimpleDirectoryReader(input_files = [uploaded_file]).load_data()\n",
    "    \n",
    "    service_context = ServiceContext.from_defaults(\n",
    "            llm=OpenAI(model=\"gpt-4-32k\", temperature=0, streaming=True, ), chunk_size=4096, chunk_overlap = 512, \n",
    "    )\n",
    "    \n",
    "    index = VectorStoreIndex.from_documents(\n",
    "        documents, service_context=service_context\n",
    "    )\n",
    "    index_query_engine = index.as_query_engine(streaming=True, similarity_top_k=2)\n",
    "    streaming_response = index_query_engine.query(query)\n",
    "\n",
    "\n",
    "    placeholder = st.empty()\n",
    "    full_text = \"\"\n",
    "\n",
    "    for text in streaming_response.response_gen:\n",
    "        full_text += text\n",
    "        time.sleep(0.1)\n",
    "        placeholder.write(full_text)\n",
    "    \n",
    "\n",
    "    return full_text\n",
    "    \n",
    "    \n",
    "\n",
    "def prompt(file):\n",
    "    with open(file,encoding=\"utf8\") as f:\n",
    "        return f.read()\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "e67c8e8e-59eb-48b1-a293-df80c1fbf77a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Voxelotor was found to be an effective treatment for sickle cell disease in children. The 1500 mg dose of voxelotor was associated with a significant decrease in hemoglobin levels and a decrease in indirect bilirubin levels from baseline to week 24. Additionally, the relative change in the percentage of reticulocytes was significantly greater in the 1500-mg voxelotor group than in the placebo group. All four measures of hemolysis showed a response that improved with increasing whole-blood concentrations of voxelotor. These results suggest that voxelotor is an effective treatment for sickle cell disease in children."
     ]
    }
   ],
   "source": [
    "streaming_response = llama_listvectorkeyword_index('RCT.pdf', 'summarize and conclude the voxelotor efficacy for parents of child patients in plain language\"')\n",
    "streaming_response.print_response_stream()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "593d900a-5905-4990-bf9f-ded04e01da67",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e5083365-2e34-4bc8-bbe1-8e35497dad15",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
